Skip to main content
HUALAN GROUP CO.,LTD. logo

HUALAN GROUP CO.,LTD. — Investor Relations & Filings

Ticker · 301027 ISIN · CNE100004MH7 Shenzhen Stock Exchange Manufacturing
Filings indexed 662 across all filing types
Latest filing 2022-04-25 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 301027

About HUALAN GROUP CO.,LTD.

https://www.gxhl.com

Hualan Group Co., Ltd. specializes in the research, development, and manufacturing of primary pharmaceutical packaging materials. The company's core product portfolio includes high-quality butyl rubber stoppers, aluminum-plastic combination caps, and plastic components designed for injectable medications and infusion sets. These products are engineered to ensure drug stability and compatibility, meeting international quality standards such as GMP. Serving a global clientele of pharmaceutical manufacturers, the group focuses on advanced material science and precision manufacturing to provide secure sealing solutions for vaccines, antibiotics, and blood products. By integrating R&D with large-scale production capabilities, the company maintains a significant role in the pharmaceutical supply chain, emphasizing safety and reliability in drug delivery systems.

Recent filings

Filing Released Lang Actions
2021年独立董事述职报告-袁公章
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director 2021 Annual Work Report" for the company 华蓝集团股份公司. It details the independent director's attendance at board meetings and shareholder meetings, opinions on company matters, investigations, protection of investor rights, committee work, and training during the 2021 fiscal year. The content is a detailed report of the independent director's activities and responsibilities over the year, which aligns with a Management Report or similar detailed management disclosure. It is not an Annual Report (10-K), Audit Report, or a brief announcement. It is not a proxy statement or voting result. The document is a narrative report on management-related activities and governance from the perspective of an independent director, fitting best under Board/Management Information (MANG). The document length is 2827 characters, which is relatively short but contains substantive content about management activities rather than just an announcement or certification. Therefore, the classification is MANG with high confidence.
2022-04-25 Chinese
关于第四届董事会第三次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion report from independent directors regarding various matters discussed at the fourth board meeting of the company. It covers opinions on profit distribution proposals, auditor reappointment, related party transactions, internal control evaluation, director and senior management remuneration, and insurance for directors and officers. The document is not a full annual report or financial statement but rather a formal opinion on governance and board-related matters to be submitted to the shareholders' meeting. It does not contain financial statements or detailed financial analysis but focuses on board and management governance issues and approvals. Therefore, it fits best under Board/Management Information (MANG). The document length is 2612 characters, which is relatively short and consistent with a board opinion or announcement rather than a full report.
2022-04-25 Chinese
关于续聘2022年度会计师事务所的公告
Audit Report / Information Classification · 95% confidence The document is an announcement regarding the reappointment of the auditing firm (an accounting firm) for the fiscal year 2022. It details the qualifications, independence, and integrity of the auditing firm, the approval process by the board and supervisory committees, and the need for shareholder approval. It does not contain any financial statements or audit results but is a formal announcement about the auditor appointment. This fits the category of an Audit Report / Information announcement, specifically about the auditor appointment and related information, but not the audit report itself. Given the detailed nature and focus on audit firm reappointment, the best classification is AR (Audit Report / Information). The document length is 3326 characters, which is short but contains substantive information about audit firm reappointment, not just a brief notice or report publication announcement. FY 2022
2022-04-25 Chinese
关于公司2022年度日常关联交易预计的公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement regarding the company's expected related party transactions for the year 2022, including historical data for 2021. It includes information about the nature of transactions, pricing policies, related parties, and independent directors' opinions. The document is an announcement of expected related party transactions and their approval process, not a financial report or audit. It is not a full annual or interim report, nor an earnings release. It is a regulatory announcement about related party transactions, which fits best under Regulatory Filings (RNS) as it does not fit other more specific categories like MANG (management changes) or CAP (capital updates). The document is over 11,000 characters, so it is not a brief report publication announcement. Therefore, the best classification is Regulatory Filings (RNS).
2022-04-25 Chinese
董事会决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the fourth board meeting of Huazhong Group Co., Ltd. It includes approvals of various reports such as the 2021 annual general manager work report, 2021 board work report, 2021 financial statements, 2022 financial budget, profit distribution plan, 2021 annual report and its summary, appointment of auditors, internal control self-assessment report, governance system revisions, related party transactions, and others. The document also mentions that these reports and proposals will be submitted to the 2021 annual shareholders meeting for approval. The document is a formal board meeting resolution announcement, not the reports themselves, and it references multiple reports disclosed elsewhere on the stock exchange information website. The document length is 6693 characters, which is substantial but the content is primarily about board meeting decisions and approvals, not the full reports. Therefore, this document fits best into the category of Board/Management Information (MANG), as it announces board meeting resolutions and management decisions rather than providing full financial reports or presentations.
2022-04-25 Chinese
关于第四届董事会第三次会议相关事项的事前认可意见
Audit Report / Information Classification · 90% confidence The document is a statement from independent directors providing prior approval opinions on matters to be discussed at the company's fourth board meeting, including the reappointment of the 2022 auditor and the forecast of related party transactions for 2022. It references regulatory compliance and internal governance but does not contain actual financial statements or detailed audit results. The document is short (1021 characters) and serves as a formal opinion or endorsement rather than a full audit report or annual report. It is not a certification letter or a report publication announcement. Given the content and nature, it fits best under Audit Report / Information (AR) as it relates to audit firm reappointment and audit-related opinions without being a full annual report. FY 2022
2022-04-25 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.